4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-15-000060
$BHCCIK 0000885590operating
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 4:51 PM ET
Size
5.4 KB
Accession
0000885590-15-000060
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Award
Restricted Share Units
2015-07-20+12,900→ 433,800 total
Footnotes (2)
- [F1]Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]1/5 of the Matching RSUs will vest each on the first, second, third, fourth and fifth anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 4:51 PM ET
- Size
- 5.4 KB